Showing results (271-280 of 413) with videos related to
Sort By:
Pageof 42
Internal and Emergency Medicine|June 21, 2012
Role of renal function on the development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancerGiulia Russo, Giovanni Cioffi, Andrea Di Lenarda, et al.Journal of Cardiac Failure|February 4, 2012
Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancerLuigi Tarantini, Giovanni Cioffi, Stefania Gori, et al.Giornale Italiano Di Cardiologia (2006)|December 23, 2023
[ANMCO/SIMEU Consensus document on the use of reversal agents of antithrombotic therapies in patients with active bleeding or at high-risk of major bleeding events]Leonardo De Luca, Francesco Rocco Pugliese, Beniamino Susi, et al.The Lancet Regional Health. Europe|May 21, 2026
Trends in sudden death-attributed mortality across Europe, 2010-2020: a retrospective population-based analysisMarco Zuin, Eloi Marijon, Kumar Narayanan, et al.JACC. Cardiovascular Imaging|January 19, 2013
LAD coronary artery myocardial bridging and apical ballooning syndromeFederico Migliore, Erica Maffei, Martina Perazzolo Marra, et al.Cardiology|July 1, 2010
Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trialGiuseppe Tarantini, Enrico Favaretto, Massimo Napodano, et al.Giornale Italiano Di Cardiologia (2006)|October 2, 2025
[Cardiovascular disease in adult cancer survivors: a new frontier for cardio-oncology]Andrea Tedeschi, Maria Laura Canale, Alessandra Greco, et al.Bioinformatics (Oxford, England)|May 11, 2016
A computational model to predict the immune system activation by citrus-derived vaccine adjuvantsFrancesco Pappalardo, Epifanio Fichera, Nicoletta Paparone, et al.Molecular Therapy. Oncology|August 2, 2026
Retraction Notice to: Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid CancerAgata Campisi, Roberta Bonfanti, Giuseppina Raciti, et al.Pediatric Cardiology|May 7, 2020
CHA2DS2-VASc Score Predicts Adverse Outcome in Patients with Simple Congenital Heart Disease Regardless of Cardiac RhythmGiorgio Faganello, Giulia Barbati, Giulia Russo, et al.Pageof 42